Complex Rehab Exemption: Know Your Protections
If you've ever been told "Medicare doesn't pay for that" while sitting in a chair that's actively hurting you, you already know why the complex rehab technology (CRT) protections matter. They're not glamorous. They're buried in fee schedules and legislative language most people never read. But they're the difference between getting a chair built around your body and getting whatever's cheapest on the shelf.
Let me walk you through what actually protects you, what doesn't, and what to do about the gaps.
What "complex rehab" actually means
CRT isn't a marketing term. It's a category defined by billing codes. On the manual side, the one that matters most is K0005 — ultralightweight manual wheelchair. On the power side, it's Group 3 power wheelchairs (K0848–K0864) and Group 2 chairs with power seating.
This matters more than most people realize. A K0004 "high-strength lightweight" chair and a K0005 ultralight look similar in a catalog photo. They are not the same product, and they are not paid the same way. K0005 chairs are the ones with adjustable axle plates, rigid frames, custom fabrication, and the fitting precision that protects your shoulders over twenty years. If your paperwork says K0004, you are not getting a complex rehab chair — no matter what the sales rep called it.
Action item: ask your supplier, in writing, which HCPCS code they're billing. Get the answer before you sign anything.
The competitive bidding exemption
Here's the fight that consumed the CRT world for most of a decade.
Medicare's competitive bidding program was designed to drive down prices on commodity equipment — walkers, hospital beds, standard wheelchairs. Complex rehab power wheelchairs themselves were excluded from the start. But CMS then tried to apply bid-derived pricing to the accessories on those chairs: the tilt systems, specialty backs, custom cushions, alternative drive controls.
That's like exempting a custom prosthetic leg but paying commodity rates for the socket. Congress delayed it repeatedly, and the Consolidated Appropriations Act of 2021 made the exemption permanent for accessories used with Group 3 complex rehab power wheelchairs. That's a real, durable win.
The honest part: complex manual wheelchair accessories never got the same permanent statutory protection. Accessories used on K0005 ultralights have lived under temporary holds and administrative discretion rather than hard law. It's the softest spot in the whole framework, and it's the one I'd verify current status on before assuming coverage for a high-end back support or custom cushion on a manual chair.
Also worth knowing: since Round 2021, CMS only awarded competitive bidding contracts for off-the-shelf back and knee braces. No wheelchair category is actively bid right now. That reduces immediate pressure — but bid-derived rates still influence the broader fee schedule, and programs can be restarted. The exemption is worth having even when the program is quiet.
Protections that come with strings
Some CRT rules look like hurdles but function as protections:
- The ATP requirement. For K0005 and Group 3 chairs, Medicare requires that a RESNA-certified Assistive Technology Professional be directly involved in selecting your equipment. This exists specifically to keep complex chairs out of order-taking channels.
- The independent specialty evaluation. A PT or OT with no financial relationship to the supplier must evaluate you. If your supplier offers to "handle the eval in-house," that's a red flag, not a convenience.
- The face-to-face physician exam within six months prior to the order.
Yes, these slow things down. They also mean the chair gets specified by someone who measured you.
What the exemption does not cover
I won't oversell this. Real limitations:
The in-the-home standard still applies. Medicare evaluates mobility need based on function inside your home. Your commute, your job, your kid's soccer field — officially irrelevant. It's an outdated rule and CRT status doesn't override it.
Seat elevation is covered; standing is not. CMS issued a national coverage determination in 2023 covering power seat elevation on Group 3 chairs and Group 2 chairs with power seating. Standing systems did not get the same treatment and remain a fight, generally decided case by case.
Medicaid varies wildly. Some states have strong CRT carve-outs written into statute. Others treat an ultralight like a shower chair. If Medicaid is your payer, the federal framework tells you very little.
What to do with this
- Confirm the code. K0005 or nothing, if you're a full-time manual user.
- Keep every document. The evaluation, the letter of medical necessity, the delivery paperwork. Denials are often paperwork failures, not coverage failures.
- Appeal. Medicare has five levels. A large share of CRT denials are overturned at redetermination or ALJ hearing. Private plans owe you external review under the ACA.
- Make the LMN specific. "Patient needs a wheelchair" loses. "Patient has a C6 injury, propels 3,000+ strokes daily, has documented right shoulder impingement, and requires an adjustable-axle rigid ultralight to reduce propulsion force" wins.
- Ask who your supplier answers to. Volume contracts shape what gets recommended more than anyone admits.
The protections exist because people fought for them. Using them well is on you — and on whoever's helping you.
Ready for a Chair That Actually Fits?
Knowing your protections is half the battle; the other half is having someone specify the chair correctly the first time so you never have to use them. The right custom ultralight, coded and documented properly, is the strongest appeal you'll never have to file.
I work directly with clients to specify and order custom ultra-lightweight wheelchairs — no middlemen, no upsells, just the chair that fits your life.
Get started at wheelchair.direct — answer a few questions and I'll reach out personally.